Provided by Tiger Trade Technology Pte. Ltd.

Co-Diagnostics, Inc.

2.52
+0.02601.04%
Volume:10.11K
Turnover:23.32K
Market Cap:5.11M
PE:-0.09
High:2.56
Open:2.48
Low:2.40
Close:2.49
52wk High:46.50
52wk Low:2.20
Shares:2.03M
Float Shares:1.80M
Volume Ratio:1.01
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.0077
EPS(LYR):-37.2229
ROE:-62.12%
ROA:-37.92%
PB:0.13
PE(LYR):-0.07

Loading ...

Co-Diagnostics Forms Joint Venture with Arabian Eagle Manufacturing for MENA Expansion

Reuters
·
Feb 09

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture PCR Pro Instrument in India

Reuters
·
Feb 05

CoSara Receives ISO 13485 Certification for PCR Platform Manufacturing

Reuters
·
Feb 04

Co-Diagnostics Cut to Hold From Buy by Maxim Group

Dow Jones
·
Jan 24

Co-Diagnostics downgraded to Hold from Buy at Maxim

TIPRANKS
·
Jan 23

Co-Diagnostics trading resumes

TIPRANKS
·
Jan 14

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:24 PM

Reuters
·
Jan 14

Nasdaq Moves to Delist Co-Diagnostics Inc. Over Bid Price Non-Compliance

Reuters
·
Jan 14

CoSara Expands Distributor Network Across India for Co-Diagnostics Inc

Reuters
·
Jan 12

Co-Diagnostics Enacts 1-for-30 Reverse Stock Split

Reuters
·
Dec 30, 2025

Co-Diagnostics Inc - Reverse Stock Split Effective January 2, 2026

THOMSON REUTERS
·
Dec 30, 2025

Co-Diagnostics Inc - Filed Amendment to Effect Reverse Stock Split of Its Common Stock at a Ratio of 1-for-30 Shares

THOMSON REUTERS
·
Dec 30, 2025

Co-Diagnostics Inc. Granted Australian Patent for Point-of-Care PCR Testing Platform

Reuters
·
Dec 29, 2025

CoSara Diagnostics Invited to Advanced TB Diagnostics Workshop in India

Reuters
·
Dec 18, 2025

Co-Diagnostics Confirms Flu Test Effectiveness Against Emerging H3N2 Mutation

Reuters
·
Dec 17, 2025

Co-Diagnostics Unveils Portable Cloud-Connected PCR Platform at Boston Conference

Reuters
·
Dec 09, 2025

CoSara Diagnostics to Showcase New PCR Tests at VIROCON 2025

Reuters
·
Dec 09, 2025

Co-Diagnostics Inc. held shareholder meeting on reverse stock split proposal

Reuters
·
Dec 06, 2025

Co-Diagnostics Initiated at Buy by Maxim Group

Dow Jones
·
Nov 26, 2025

Co-Diagnostics Inc : Maxim Group Initiates Coverage With Buy Rating; Target Price $1.5

THOMSON REUTERS
·
Nov 26, 2025